Pulmonary venous dilatation in pulmonary veno-occlusive disease

Massumi, Ali; Woods, Larry; Mullins, Charles E.; Nasser, Wael; Hall, Robert J.

doi:10.1016/0002-9149(81)90092-8

Cited by 36 publications

(9 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There was Doppler evidence of mild pulmonary insufficiency (sample volume placed in right ventricular outflow tract) in six of these twelve children, although only two of them had evidence of pulmonary insufficiency at auscultation. Repeat cardiac catheterisation was performed in ten patients [6][7][8][9][10][11][12][13][14][15] months (mean 10 months) after balloon dilatation.…”

Section: Pulmonary Valve Stenosismentioning

confidence: 99%

Transcatheter treatment of pulmonary stenosis and coarctation of the aorta: experience with percutaneous balloon dilatation.

Rao¹

1986

Heart

View full text Add to dashboard Cite

Twenty two children (age range 4 months-20 years) with pulmonary valve stenosis and ten children (age range 1 month-11 years) with coarctation of the aorta underwent balloon dilatation in the 29 month period between October 1983 and February 1986. Number 5-9 French catheters with 5-20 mm balloons were used according to the size of the angiographically measured pulmonary valve annulus or coarcted segment and the aorta proximal to coarctation. The peak inflation pressure used in the balloons varied from 2-5 atm (202-505 kN/m2) for pulmonary valve stenosis and 4-8 atm (404-808 kN/m2) for coarctation, and inflation lasted 8-15 s. At least four balloon dilatations were performed in every case. After balloon dilatation the mean (SD) peak systolic pressure gradient across the pulmonary valve fell from 98 (39) to 33 (13) mm Hg. The cardiac index did not change. After balloon dilatation of aortic coarctation the systolic pressure in the descending aorta rose from 86.4 (17.7) to 107.8 (20) mm Hg and the peak systolic pressure difference across the coarctation fell from 44.1 (19.1) to 8.5 (8.5) mm Hg. The diameter of the angiographically measured coarcted segment increased, the Doppler estimate of the pressure difference across the coarctation decreased, and the femoral pulses improved. There were no important complications. Long term follow up results for balloon dilatation of pulmonary valve stenosis were excellent. Similar follow up was not available for patients after dilatation of aortic coarctation. Percutaneous balloon dilatation for pulmonary stenosis and coarctation of the aorta is a safe and effective alternative to operation. It is the treatment of choice for pulmonary valve stenosis and it may become so for coarctation of the aorta in young children if long term results are favourable.

show abstract

Section: Pulmonary Valve Stenosismentioning

confidence: 99%

Transcatheter treatment of pulmonary stenosis and coarctation of the aorta: experience with percutaneous balloon dilatation.

Rao¹

1986

Heart

View full text Add to dashboard Cite

show abstract

“…A total of 584 articles on FM were retrieved. Eight studies, including two retrospective studies (15,22) and six case reports (7,(23)(24)(25)(26)(27), were analyzed. Only the information on the PV was extracted from these articles.…”

Section: Resultsmentioning

confidence: 99%

“…In the study with the largest sample size (15), the patients had stenosis in PAs, PVs, and SVC, the mortality of the patients received PV interventions was unknown. Of the 31 patients receiving catheter-based treatments for PVS (7,15,(22)(23)(24)(25)(26)(27), 15 had detailed information (7,(22)(23)(24)(25)(26)(27). Among these 15 patients, 7 died (22)(23)(24)27).…”

Section: Mortalitymentioning

confidence: 99%

Balloon angioplasty or stent implantation for pulmonary vein stenosis caused by fibrosing mediastinitis: a systematic review

Duan

Zhou

et al. 2019

Cardiovasc. Diagn. Ther.

View full text Add to dashboard Cite

Fibrosing mediastinitis (FM) is a very rare disease, often caused by histoplasmosis capsulatum, tuberculosis, sarcoidosis, autoimmunity and other diseases, such as IgG 4-related diseases. Fibrous structures in the mediastinum compress the pulmonary artery, pulmonary vein, superior vena cava, esophagus, trachea and cardiac vessels, leading to clinical symptoms. Drug therapeutic modality for pulmonary vein stenosis (PVS) caused by FM is palliative in essence and with limited efficacy, whereas surgical treatment causes high mortality. In recent years, catheter-based treatment to FM-caused PVS has emerged as a promising therapeutic modality, however, the safety and effectiveness of this modality remain unclear. Therefore, a systematic review on the safety and efficacy of the catheter-based treatment for PVS caused by FM was performed, in the hope to shed lights on the alternative therapeutic strategy to this fatal disease.

show abstract

“…Balloon dilatation techniques have been applied to other congenital and post-operative stenotic lesions, namely, mitral [65,66] and tricuspid [ 11 valve stenosis, discrete subaortic membranous stenosis [67,68] pulmonary vein stenosis [69,70], patent ductus arteriosus (for improving systemic perfusion [7 1,72]), vena caval [73,74] or interatrial baffle obstruction [75] following Mustard or Senning operation for transposition of the great arteries, supravalvar pulmonic stenosis following arterial switch operation for transposition of the great arteries, stenosed Blalock-Taussig shunt [76] and stenosed bioprosthetic valves in pulmonary [77,78], aortic [79], mitral [SO], and tricuspid [81] positions. However, the success of balloon angioplasty varied depending upon the lesion dilated and technique of dilatation used.…”

Section: Other Lesionsmentioning

confidence: 99%

Balloon dilatation in infants and children with cardiac defects

Rao

1989

Cathet. Cardiovasc. Diagn.

View full text Add to dashboard Cite

Pulmonary venous dilatation in pulmonary veno-occlusive disease

Cited by 36 publications

References 13 publications

Transcatheter treatment of pulmonary stenosis and coarctation of the aorta: experience with percutaneous balloon dilatation.

Transcatheter treatment of pulmonary stenosis and coarctation of the aorta: experience with percutaneous balloon dilatation.

Balloon angioplasty or stent implantation for pulmonary vein stenosis caused by fibrosing mediastinitis: a systematic review

Balloon dilatation in infants and children with cardiac defects

Contact Info

Product

Resources

About